SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-029044
Filing Date
2023-05-12
Accepted
2023-05-12 16:22:23
Documents
2
Period of Report
2023-05-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2235
2 POA DOCUMENT poa.txt EX-24 2880
  Complete submission text file 0001209191-23-029044.txt   6557
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL PHARMACEUTICALS INC (Issuer) CIK: 0001445499 (see all company filings)

IRS No.: 263058238 | State of Incorp.: DE | Fiscal Year End: 0426
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 24 LUCILLE LANE DIX HILLS NY 11746
Business Address
Kalb Michael Wayne (Reporting) CIK: 0001678248 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40353 | Film No.: 23916143